Technology

Hoth

$2.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.24 (-9.72%) Today
-$0.03 (-1.35%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Hoth and other stocks, options, and ETFs commission-free!

About HOTH

Hoth Therapeutics, Inc. Common Stock, also called Hoth, is a development stage biopharmaceutical company, which engages in the provision and development of therapeutic platform. The company focuses on the patients suffering from conditions such as atopic dermatitis, also known as eczema. It offers BioLexa Platform, a proprietary, patented, drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern in May 2017 and is headquartered in New York, NY. The listed name for HOTH is Hoth Therapeutics, Inc. Common Stock.

CEO
Robbie Knie
Employees
3
Headquarters
New York, New York
Founded
2017
Market Cap
28.94M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.40M
High Today
$2.38
Low Today
$2.21
Open Price
$2.34
Volume
1.19M
52 Week High
$7.20
52 Week Low
$1.56

Collections

HOTH Earnings

-$0.41
-$0.27
-$0.14
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 1, Pre-Market

You May Also Like

MLCO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure